Facioscapulohumeral Muscular Dystrophy clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for

  • AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

    open to eligible people ages 16-70

    A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    San Diego, California and other locations

  • AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Sorry, accepting new patients by invitation only

    A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    San Diego, California and other locations

Last updated: